The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125236331 12523633 1 I 201512 20160623 20160704 20160704 EXP JP-ALXN-A201604717AA ALEXION 78.00 YR F Y 85.00000 KG 20160704 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125236331 12523633 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, QW 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
125236331 12523633 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
125236331 12523633 3 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 1 DF, DAILY 0 CAPSULE QD
125236331 12523633 4 C REBAMIPIDE REBAMIPIDE 1 Oral 3 DF, DAILY 0 TABLET QD
125236331 12523633 5 C REBAMIPIDE REBAMIPIDE 1 Oral 1 DF, DAILY 0 TABLET QD
125236331 12523633 6 C VASOLAN /00014302/ VERAPAMIL HYDROCHLORIDE 1 Oral 1 DF, DAILY 0 TABLET QD
125236331 12523633 7 C VASOLAN /00014302/ VERAPAMIL HYDROCHLORIDE 1 Oral 3 DF, DAILY 0 TABLET QD
125236331 12523633 8 C WARFARIN WARFARIN 1 Oral 3 DF, DAILY 0 TABLET QD
125236331 12523633 9 C WARFARIN WARFARIN 1 Oral 3 DF, DAILY 0 TABLET QD
125236331 12523633 10 C RENIVACE ENALAPRIL 1 Oral 1 DF, DAILY 0 TABLET QD
125236331 12523633 11 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Unknown 20 MG, DAILY 0 20 MG QD
125236331 12523633 12 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Unknown 10 MG, UNK 0 10 MG
125236331 12523633 13 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Unknown 5 MG, UNK 0 5 MG
125236331 12523633 14 C FOLIAMIN FOLIC ACID 1 Unknown 5 MG, DAILY 0 5 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125236331 12523633 1 Paroxysmal nocturnal haemoglobinuria
125236331 12523633 3 Product used for unknown indication
125236331 12523633 4 Product used for unknown indication
125236331 12523633 6 Product used for unknown indication
125236331 12523633 8 Product used for unknown indication
125236331 12523633 10 Product used for unknown indication
125236331 12523633 11 Product used for unknown indication
125236331 12523633 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125236331 12523633 OT
125236331 12523633 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125236331 12523633 Breast cancer
125236331 12523633 Nasopharyngitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125236331 12523633 1 20130529 20130621 0
125236331 12523633 2 20130628 0
125236331 12523633 3 20130501 0
125236331 12523633 4 20130501 0
125236331 12523633 5 20130501 0
125236331 12523633 6 20130501 0
125236331 12523633 8 20130501 20130306 0
125236331 12523633 9 20130312 0
125236331 12523633 10 20150814 0
125236331 12523633 11 20130525 20130530 0
125236331 12523633 12 20160531 20160606 0
125236331 12523633 13 20160607 0
125236331 12523633 14 20130626 0